Robert Gabbay, MD, PhD, delineates key differences between type 1 and type 2 diabetes, including autoimmune antibodies, insulin resistance, and insulin deficiency.
Semaglutide, Tirzepatide Cut Dementia, Stroke Risk in Type 2 Diabetes
Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.
Read More
Five Years Later: Ongoing COVID-19 Challenges, Next Steps
On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.
Listen
Potential Link Found Between Obesity and Myasthenia Gravis Exacerbation
Three patient outcomes were measured in this new study: time to onset of ocular-related myasthenia gravis, Activities of Daily Living response, and Minimal Symptom Expression.
Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi
Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.
Colorectal Cancer Shared Care Model Gains Support From Clinicians
New insights highlight clinician support for shared survivorship care and identify key factors for effective implementation.
HALP Score Acts as Prognostic Biomarker for Survival Outcomes in NSCLC
The hemoglobin, albumin, lymphocyte, and platelet (HALP) score can help to guide treatment decisions in patients living with non–small cell lung cancer (NSCLC).